Last reviewed · How we verify
12 Week, Multi-center, Randomized, Double-blind, Double Dummy, Parallel Group Trial Comparing the Efficacy and Safety of 40 & 80 mg Telmisartan and 50 & 100 mg Losartan in the Treatment of 150 Pairs of Primary Hypertension Patients
Using Losartan as a comparator, to evaluate the efficacy and safety of telmisartan in the treatment of the mild to moderate primary hypertension patients in China
Details
| Lead sponsor | Boehringer Ingelheim |
|---|---|
| Phase | Phase 3 |
| Status | COMPLETED |
| Enrolment | 330 |
| Start date | 2000-07 |
Conditions
- Hypertension
Interventions
- Low dose of telmisartan
- High dose of telmisartan
- Low dose of losartan
- High dose of losartan
Primary outcomes
- Changes in mean sitting valley value of DBP — 8 weeks after start of treatment
The valley value of blood pressure refers to the blood pressure measured prior to the next administration of antihypertensives